"I think this should be the very first step in someone's journey if they're interested in GLP-1s," Reitano said
How Tirzepatide Works: Weekly subcutaneous injection Dual receptor activation (GLP-1 + GIP) Enhanced metabolic benefits Greater average weight loss in clinical studies Side-by-Side Comparison: Semaglutide vs Tirzepatide Effectiveness Semaglutide: Average 12-15% body weight loss Tirzepatide: Average 15-20% body weight loss Both medications show significant results, but individual responses vary
In some cases, blood tests are needed
The product has been developed to support muscle maintenance and digestive health, and tailored specifically for GLP-1 users who face unique nutrition challenges
MECHANISM OF ACTION: A dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist activates both the GIP and GLP-1 receptors, and as a result it effectively regulates glucose levels, reduces appetite and promotes weight loss
Digital health tools and patient support programs will play a vital role in long-term compliance
